HRMY (Harmony Biosciences Holdings, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) is a publicly traded Healthcare sector company. As of May 21, 2026, HRMY trades at $31.90 with a market cap of $1.73B and a P/E ratio of 12.41. HRMY moved +3.09% today. Year to date, HRMY is -14.61%; over the trailing twelve months it is -11.90%. Its 52-week range spans $25.52 to $41.61. Analyst consensus is buy with an average price target of $43.44. Rallies surfaces HRMY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns HRMY stock?
Hedge funds tracked by Rallies that own HRMY include Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Harmony Biosciences Holdings, Inc. Common Stock.
HRMY Key Metrics
Key financial metrics for HRMY
Metric
Value
Price
$31.90
Market Cap
$1.73B
P/E Ratio
12.41
EPS
$2.53
Dividend Yield
0.00%
52-Week High
$41.61
52-Week Low
$25.52
Volume
22
Avg Volume
0
Revenue (TTM)
$899.11M
Net Income
$145.62M
Gross Margin
76.55%
Top Hedge Funds Holding HRMY
Bridgewater Associates holds 251.51K shares of HRMY, changed +10.06% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own HRMY include Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Harmony Biosciences Holdings, Inc. Common Stock.
Does Rallies show 13F holders for HRMY?
Yes. Rallies tracks hedge fund and 13F ownership data for HRMY, including fund names, share counts, latest tracked quarter, and position changes when available.
Is HRMY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HRMY. It does not provide personalized investment advice.
